Translations:Biosimilar/29/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,847 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 09:54, 20 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Biosimilar)
{| class="wikitable"
|+European Union approved biosimilars
|-
! Active substance !! Reference product !! Biosimilar medicines
|-
| [[Adalimumab]]  || Humira || Amgevita, Amsparity, Cyltezo, Halimatoz, Hefiya, Hukyndra, Hulio, Hyrimoz, Idacio, Imraldi, Kromeya, Libmyris, Solymbic, Trudexa, Yuflyma
|-
| [[Bevacizumab]] || Avastin || Abevmy, Alymsys, Aybintio, Equidacent, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev
|-
| [[Enoxaparin sodium]]  || Clexane|| Inhixa, Thorinane
|-
| [[Epoetin alfa]] || Eprex/Erypo || Abseamed, Binocrit, Epoetin Alfa Hexal, Retacrit, Silapo
|-
| [[Etanercept]]  || Enbrel || Benepali, Erelzi, Lifmior, Nepexto
|-
| [[Filgrastim]]  || Neupogen || Accofil, Biograstim, Filgrastim Hexal, Filgrastim ratiopharm, Grastofil, Nivestim, Ratiograstim, Tevagrastim, Zarzio
|-
| [[Follitropin alfa]] || Gonal-F || Bemfola, Ovaleap
|-
| [[Infliximab]]  || Remicade || Flixabi, Inflectra, Remsima, Zessly
|-
| [[Insulin aspart]]  || NovoRapid || Fiasp, Insulin aspart Sanofi, Kirsty, NovoMix, Ryzodeg
|-
| [[Insulin glargine]]  || Lantus || Abasaglar, Semglee
|-
| [[Insulin lispro]]  || Humalog || Insulin lispro Sanofi
|-
| [[Pegfilgrastim]] || Neulasta || Cegfila, Fulphila, Grasustek, Pelgraz, Pelmeg, Udenyca, Stimufend, Ziextenzo
|-
| [[Ranibizumab]] || Lucentis || Byooviz, Ranivisio, Ximluci
|-
| [[Rituximab]] || MabThera || Blitzima, Ritemvia, Rituzena, Rixathon, Riximyo, Ruxience, Truxima
|-
| [[Somatropin]]  || Genotropin || Omnitrope
|-
| [[Teriparatide]]  || Forsteo || Movymia, Terrosa
|-
| [[Tocilizumab]] || RoActemra || Tyenne
|-
| [[Trastuzumab]] || Herceptin || Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera, Zercepac
|}
European Union approved biosimilars
Active substance Reference product Biosimilar medicines
Adalimumab Humira Amgevita, Amsparity, Cyltezo, Halimatoz, Hefiya, Hukyndra, Hulio, Hyrimoz, Idacio, Imraldi, Kromeya, Libmyris, Solymbic, Trudexa, Yuflyma
Bevacizumab Avastin Abevmy, Alymsys, Aybintio, Equidacent, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev
Enoxaparin sodium Clexane Inhixa, Thorinane
Epoetin alfa Eprex/Erypo Abseamed, Binocrit, Epoetin Alfa Hexal, Retacrit, Silapo
Etanercept Enbrel Benepali, Erelzi, Lifmior, Nepexto
Filgrastim Neupogen Accofil, Biograstim, Filgrastim Hexal, Filgrastim ratiopharm, Grastofil, Nivestim, Ratiograstim, Tevagrastim, Zarzio
Follitropin alfa Gonal-F Bemfola, Ovaleap
Infliximab Remicade Flixabi, Inflectra, Remsima, Zessly
Insulin aspart NovoRapid Fiasp, Insulin aspart Sanofi, Kirsty, NovoMix, Ryzodeg
Insulin glargine Lantus Abasaglar, Semglee
Insulin lispro Humalog Insulin lispro Sanofi
Pegfilgrastim Neulasta Cegfila, Fulphila, Grasustek, Pelgraz, Pelmeg, Udenyca, Stimufend, Ziextenzo
Ranibizumab Lucentis Byooviz, Ranivisio, Ximluci
Rituximab MabThera Blitzima, Ritemvia, Rituzena, Rixathon, Riximyo, Ruxience, Truxima
Somatropin Genotropin Omnitrope
Teriparatide Forsteo Movymia, Terrosa
Tocilizumab RoActemra Tyenne
Trastuzumab Herceptin Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera, Zercepac
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Biosimilar/29/en&oldid=130338"